Valuation: Mega Lifesciences

Market Cap 3.01TCr 90Cr 79Cr 74Cr 68Cr 127Cr 8.62TCr 128.14Cr 891.5Cr 345.77Cr 4.4TCr 337.43Cr 330.05Cr 14TCr P/E 2026 *
12.7x
P/E 2027 * 12.1x
Enterprise Value 2.55TCr 76Cr 67Cr 63Cr 58Cr 107.51Cr 7.3TCr 108.47Cr 754.67Cr 292.7Cr 3.72TCr 285.64Cr 279.39Cr 12TCr EV / Sales 2026 *
1.77x
EV / Sales 2027 * 1.62x
Free-Float
38.66%
Yield 2026 *
5.1%
Yield 2027 * 5.5%
1 day-4.17%
1 week-4.17%
Current month-4.17%
1 month-6.76%
3 months+0.73%
6 months+9.52%
Current year+2.99%
1 week 34.25
Extreme 34.25
36.75
1 month 34.25
Extreme 34.25
37
Current year 31.5
Extreme 31.5
40
1 year 27.75
Extreme 27.75
40
3 years 24.3
Extreme 24.3
46.75
5 years 24.3
Extreme 24.3
56.5
10 years 17.9
Extreme 17.9
56.5
Manager TitleAgeSince
Chief Executive Officer 64 01/01/1988
Director of Finance/CFO 62 01/01/1997
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 62 01/01/1998
Director/Board Member 64 01/01/2013
Director/Board Member 73 01/02/2013
Date Insider Type Main position Quantity % Market Cap. Importance
29/04/25 Buy

Chief Executive Officer

1,00,000 0.0115%
28/04/25 Buy

Chief Executive Officer

50,000 0.0057%
28/04/25 Buy

Chief Executive Officer

1,50,000 0.0172%
Change 5-day change 1-year change 3-year change Capi.($)
-4.17%-4.17%+13.11%-24.59% 94Cr
+2.68%+3.87%+58.22%+114.68% 1,02600Cr
+0.56%+1.27%+53.29%+68.65% 65TCr
+0.02%+0.99%+19.10%+73.58% 47TCr
+0.06%+0.25%+37.03%+45.71% 35TCr
+1.16%+4.10%+21.99%+29.39% 27TCr
-0.24%+2.18%+10.14%+12.26% 26TCr
-0.01%+7.89%+41.57%+51.68% 22TCr
-1.11%+1.36%+30.85%+99.56% 19TCr
+0.30%-7.19%-32.43%-60.56% 17TCr
Average -0.07%+0.78%+25.29%+41.04% 36TCr
Weighted average by Cap. +0.90%+1.25%+37.29%+67.66%

Financials

2026 *2027 *
Net sales 1.43TCr 43Cr 38Cr 35Cr 32Cr 61Cr 4.11TCr 61Cr 425.22Cr 164.92Cr 2.1TCr 160.94Cr 157.42Cr 6.89TCr 1.57TCr 47Cr 41Cr 39Cr 35Cr 66Cr 4.49TCr 67Cr 464.26Cr 180.07Cr 2.29TCr 175.72Cr 171.88Cr 7.52TCr
Net income 223.08Cr 6.67Cr 5.86Cr 5.52Cr 5.04Cr 9.42Cr 639.47Cr 9.5Cr 66Cr 26Cr 326.12Cr 25Cr 24Cr 1.07TCr 248.53Cr 7.43Cr 6.53Cr 6.15Cr 5.62Cr 10Cr 712.45Cr 11Cr 74Cr 29Cr 363.34Cr 28Cr 27Cr 1.19TCr
Net Debt -461.67Cr -14Cr -12Cr -11Cr -10Cr -19Cr -1.32TCr -20Cr -136.83Cr -53Cr -674.93Cr -52Cr -51Cr -2.22TCr -471.98Cr -14Cr -12Cr -12Cr -11Cr -20Cr -1.35TCr -20Cr -139.88Cr -54Cr -689.99Cr -53Cr -52Cr -2.27TCr
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
24/26/24 THB 34.50 -4.17% 22,85,556
23/26/23 THB 36.00 0.00% 7,85,912
22/26/22 THB 36.00 +0.70% 8,83,660
21/26/21 THB 35.75 0.00% 6,92,753
18/26/18 THB 35.75 0.00% 8,97,968
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
34.50THB
Average target price
42.71THB
Spread / Average Target
+23.81%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEGA Stock